Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Liminatus Pharma Inc. (LIMN) had Weighted-Average Shares Outstanding (Diluted) of 23.30M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$0.11M |
|
-- |
|
-- |
|
$1.12M |
|
$-1.12M |
|
$1.23M |
|
$0.11M |
|
$0.11M |
|
$0.11M |
|
$0.11M |
|
$0.11M |
|
$0.11M |
|
$-1.12M |
|
$-1.12M |
|
23.30M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
23.30M |
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$1.78M |
|
$0.00M |
|
$0.13M |
|
$1.91M |
|
$10.52M |
|
-- |
|
$0.20M |
|
$10.72M |
|
$-8.81M |
|
$-8.81M |
|
$-8.81M |
|
26.02M |
|
| Cash Flow Statement Financials | |
$-8.98M |
|
$-0.78M |
|
$11.03M |
|
$0.06M |
|
$1.34M |
|
$1.28M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.17 |
|
-- |
|
-- |
|
-- |
|
-0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1.29% |
|
-1.29% |
|
5.93% |
|
-1.29% |
|
$-0.34 |
|
$-0.39 |
|
$-0.39 |
|